GO
Biotech Stocks that Hedge Funds are Buying
For those who are willing to take the risk... ▼ 
Unless stated otherwise, the information presented here is based on the latest SEC 13F/D/G filings. List last updated 2017-09-20.
* All returns updated as of 2017-12-15
Rotate to view more data fields 📱
Closed
Symbol
Company
Stock Pick Influencer
Initial Date
Initial Price ($)
Close Date
Close Price ($)
Return (%)
 
ALDER BIOPHARMACEUTICALS INC
Bihua Chen
2016-06-10
29.8800
2017-05-17
18.6500
(37.58)
 
ASCENDIS PHARMA A S
Peter Kolchinsky
2016-06-10
13.4600
2017-05-17
28.3500
110.62
 
ARRAY BIOPHARMA INC
Mark Lampert
2016-06-10
3.5100
2017-02-16
11.1800
218.52
 
CLOVIS ONCOLOGY INC
William Edwards
2016-06-10
14.1100
2016-12-08
37.3400
164.64
 
IRONWOOD PHARMACEUTICALS INC
Roberto Mignone
2016-06-10
12.8700
2016-11-15
16.7600
30.23
 
SAREPTA THERAPEUTICS INC
Joseph Edelman
2016-06-10
19.9500
2016-08-16
24.9400
25.01
 
NEKTAR THERAPEUTICS
Peter Kolchinsky
2016-06-10
15.8700
2016-08-16
17.5200
10.40
 
KERYX BIOPHARMACEUTICALS INC
Seth Klarman
2016-06-10
5.9300
2016-08-16
4.3800
(26.14)
 
TESARO INC
Steve Cohen
2016-06-10
40.3400
2016-08-16
94.6500
134.63
 
Stock Ideas lists present the best investment ideas uncovered from hedge fund holdings by HedgeMind and do not necessarily reflect any past or present positions held by HedgeMind. Performance results reflect the value of each position on specified or closed date compared to the initial price. Performance data represent past performance, which is not a guarantee of future results, and do not take into account dividends paid, interest earned and actual commissions paid.